Print Issue: September 01, 2008

Drug Change May Aid Islet Transplant Patients

SAN FRANCISCO—Nephrologists should consider a switch to tacrolimus and mycophenolate mofetil (TacMMF) in diabetic patients undergoing clinical islet transplantation (CIT) who are unable to tolerate sirolimus, Canadian researchers said.

U.K. Team: GFR Estimates Important

SAN FRANCISCO—British researchers have endorsed U.S. guidelines stating that screening diabetic patients for renal disease should involve estimated glomerular filtration rate (eGFR) in addition to testing for albuminuria.

Scan May Reveal PCa Spread

An engineered version of the common cold virus could indicate within days, rather than weeks or months, whether treatment has halted the spread of prostate cancer.

Data Confirm Sunitinib’s Superiority

CHICAGO—Sunitinib (Sutent) remains a reference standard for the first-line treatment of metastatic renal cell carcinoma (RCC), with updated findings from a phase 3 trial confirming the superior efficacy of this agent over interferon-alfa, researchers reported here at the American Society of Clinical Oncology annual meeting.

Next post in Kidney Stones